These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oxygen toxicity in the bleomycin patient. Callery J; Brandl A J Post Anesth Nurs; 1988 Jun; 3(3):139-43. PubMed ID: 2458460 [No Abstract] [Full Text] [Related]
6. The spectrum of drug-induced pulmonary disease. Rosenow EC Ann Intern Med; 1972 Dec; 77(6):977-91. PubMed ID: 4118760 [No Abstract] [Full Text] [Related]
7. The role of screening and monitoring for bleomycin pulmonary toxicity. Shippee BM; Bates JS; Richards KL J Oncol Pharm Pract; 2016 Apr; 22(2):308-12. PubMed ID: 25736276 [TBL] [Abstract][Full Text] [Related]
8. Bleomycin-induced pulmonary nodules: a variant of bleomycin pulmonary toxicity. Zucker PK; Khouri NF; Rosenshein NB Gynecol Oncol; 1987 Nov; 28(3):284-91. PubMed ID: 2445636 [TBL] [Abstract][Full Text] [Related]
9. Bleomycin therapy and anaesthesia. The possible hazards of oxygen administration to patients after treatment with bleomycin. Allen SC; Riddell GS; Butchart EG Anaesthesia; 1981 Jan; 36(1):60-3. PubMed ID: 6162398 [TBL] [Abstract][Full Text] [Related]
11. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin. Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary toxicity of bleomycin: is G-CSF a risk factor? Bastion Y; Coiffier B Lancet; 1994 Aug; 344(8920):474. PubMed ID: 7520108 [No Abstract] [Full Text] [Related]